Risk-based strategies are superior to the U.S. Preventive Services Task Force (USPSTF) criteria for optimizing efficiency and ...

A biennial report from the American Association for Cancer Research cites progress in narrowing US cancer disparities, as well as ongoing challenges.

Lung cancer screening promises to find cancer early and treat it before it progresses. But a year on, issues have emerged.

Lung cancer remains the leading cause of cancer-related deaths worldwide and is generally thought to arise from mutations acquired over a lifetime through environmental exposures.

Background Sociodemographic inequalities impact patients with non-small cell lung cancer (NSCLC). Advances in novel ...

In this cohort study, 16 lung cancer risk prediction models demonstrated variation in screening efficiency and sensitivity ...

At Science Day, Moderna outlined growth plans across infectious-disease vaccines, Intismeran, and rare-disease therapeutics. ...

Pfizer (NYSE:PFE) oncology updates and IBRANCE expansion unfold within S&P 500 healthcare segment, alongside lung cancer ...

New countywide data that breaks down cancer cases at the census tract level is helping to inform the way providers care for ...

Lung cancer screening mortality rates vary by state in 2024, with data from the American Cancer Society highlighting key regional differences.

Methods We conducted a cost-effectiveness analysis in the Yorkshire Lung Screening Trial (YLST) population comparing three ...

Why a global giant is buying this soaring share. The post This ASX healthcare stock is up 1,900%. One top fundie wants more appeared first on The Motley Fool Australia.